| Date Filed | Type | Description |
| 10/15/2021 |
4
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Converted 1,615,427 shares
@ $0
Converted 1,615,427 preferred shares
@ $0 |
|
| 10/15/2021 |
3
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 3 on Theseus Pharmaceuticals, Inc. |
| 04/07/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/27/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 02/27/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 02/21/2017 |
SC 13D/A
| Sarissa Capital Management LP reports a 0% stake in ARIAD Pharmaceuticals, Inc. |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/16/2017 |
8-K
| Quarterly results |
| 02/16/2017 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Haimovitz Jules (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Bickerstaff George (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Herron Jennifer Lyn (Exec V.P. Chief Comm'l Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Gansler Jayne M. (Senior V.P. Human Resources) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Panayiotopoulos Paris (President and CEO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Protopapas Anna (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Soni Manmeet Singh (EVP, CFO & Treasurer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| Kogan Elona Esq. (Sr. V. P. - General Counsel) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/16/2017 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 100% stake in ARIAD PHARMACEUTICALS INC |
| 02/16/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|